Organization Launches Two Global Site Advisory Groups at Society for Clinical Research Sites' Global Site Solutions Summit
BOCA RATON, FL - inVentiv Health, a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market, today announced the launch of two global Site Advisory Groups (SAGs) at the annual Global Site Solutions Summit. These activities are part of the company's commitment to enhanced collaboration with investigative sites, who are essential partners in trial success. "Clinical trial sites are on the forefront of successful trials. Recognizing this, we're bringing clinical trial stakeholders together to create more innovative approaches to trial development. By working directly with sites, we can better address the challenges they face and leverage their rich insights," said Susan Stansfield, Ph.D., Executive Vice President, Site Centricity Unit, Clinical Division. "This increased collaboration will allow us to enhance site resource offerings." The goal of the inVentiv-hosted SAGs is to serve as forums to pinpoint key areas for improvement in the critical study start-up phase where incremental changes can have a significant impact on overall trial results. These SAGs, which will include global representation, include:
Leaders from inVentiv Health's Site Centricity Unit (SCU) will explore ways to further collaborate with sites by leading and participating in key discussions at the Summit on Saturday, October 15:
Susan Stansfield, Executive Vice President, Site Centricity Unit
SITEVISION 2020™ – Panelist (8:50-9:45 am) Uncover Realities to Become the "Site of Choice" – Breakout Moderator (1:00-2:00 pm)
Nancy Perrella, Senior Director, QA & RC
Surviving a Regulatory Inspection – Breakout Panelist (2:30-3:00 pm) The SCU, comprised of site effectiveness and efficiency experts, was created to provide focused attention and constant innovation at the site level. The group works to understand site needs and develops resources to support sites in delivering enhanced trial execution. For example, SCU has created a Site Relationship Manager who can be deployed to the most heavily utilized sites to streamline operations and uncover actionable insights. View a
video about SCU and inVentiv Health
to learn more.
About inVentiv Health
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services, processes and integrated solutions that improve client performance. With more than 15,000 employees and the ability to support clients in 90 countries, our global scale and deep therapeutic expertise enable inVentiv to help clients successfully navigate an increasingly complex environment. For more information, visit
inVentivHealth.com
.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.